Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

App-Based exercise program aims to ease arthritis symptoms in underserved patients

NCT ID NCT07642622

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a mobile app called ExerciseRx can help people with axial spondyloarthritis (a type of arthritis affecting the spine and joints) exercise more and improve their symptoms. Forty adults who are not very active will either use the app for guided exercises and step goals or continue their usual care. Researchers will measure how easy the app is to use and whether it leads to better physical function and less disease activity over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ExerciseRx app with guided home exercises and step-count goals
What this could lead to
If it works, this could offer a practical, low-cost way for people with axial spondyloarthritis to manage symptoms through exercise, especially those with limited access to care.
What could go wrong
This is a small, early feasibility study with only 40 participants. The app may not be easy to use for everyone, and any symptom improvements may be modest or not last beyond the 12-week study period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of axial spondyloarthritis by a rheumatologist * English speaking * Insufficiently active (less than 150 minutes of moderate intensity aerobic activity per week) * Willing to wear a Fitbit for the study duration * Willing to have or create a Google account and download the Google Health app (previously known as the Fitbit app) Exclusion Criteria: * Currently pregnant * International travel or any circumstance causing lack of access to wi-fi/Internet at any point during the study period * Recent or planned surgery that may affect ability to engage in physical activity * Unable to exercise for health reasons, or a provider has recommended against exercising for safety/health reasons * Unable to walk safely without difficulty, or is a fall risk (i.e., 3+ falls in past 6 months) * History of a fall resulting in a fracture or head injury in the past 6 months * Cardiovascular contraindicators for physical activity, or history of cardiovascular problems that may be exacerbated by physical activity, as defined by their rheumatologist * Diabetes causing hypoglycemia following physical activity

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Axial spondyloarthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Axial Spondyloarthritis Motor Activity spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Harborview Medical Center

    RECRUITING

    Seattle, Washington, 98104, United States

  • University of Washington

    RECRUITING

    Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.